Navigation

News

Your contact person

Manager PR & Communications Jan Phillip Denkers

Filter reset
The innovative solutions for the transport of living cells are now also available on the market in the USA. (Image: ©Cellbox Solutions GmbH)

Cellbox Solutions Establishes Subsidiary in the USA

Cellbox Solutions GmbH, developer of the patented Cellbox technology, has founded their U.S. company and is now selling products directly to the U.S./North American market. ...

Read more …
The facility employs J.POD® technology that uses autonomous clean rooms to run small, highly intensified production processes, thereby reducing the cost of biologics manufacturing. (Picture: ©Benjamin Benschneider)

Just - Evotec Biologics opens J.POD® 1 US

Evotec SE announced the opening of the company’s late-stage clinical and commercial biologics cGMP manufacturing facility (J.POD® 1 US) in Redmond, Washington. ...

Read more …
Funds to be used to obtain clinical proof of concept in two programs and to accelerate innovative pipeline focused on restoring immune tolerance to treat and potentially cure autoimmune diseases (Picture: ©Topas Therapeutics)

Topas Therapeutics Extends Series B

Topas Therapeutics GmbH (Topas), a private biotechnology company developing immune tolerance-inducing drugs to treat and potentially cure a variety of autoimmune diseases, today ...

Read more …
Evotec creates further opportunities for long-term growth with "Campus Levi-Montalcini" in Verona. (Picture: ©Z S / Unsplash)

Evotec creates long-term growth opportunities

Evotec SE announced that Evotec has added significant opportunities for further, long-term growth by acquiring the Verona site from GlaxoSmithKline SpA (“GSK”). ...

Read more …
From left to right: Robert Feidenhans'l, Nicole Elleuche, Friederike Kampschulte, Katharina Fegebank. (Picture: ©European XFEL / Axel Heimken)

New accommodation for XFEL's global researchers

Katharina Fegebank, Senator for Research, Science and Equality in Hamburg, and Friederike Kampschulte, Head of the Science Department at the Ministry of Education, Science and ...

Read more …
How do virus variants arise and how do they spread? (Picture: ©CDC/ Alissa Eckert, MSMI; Dan Higgins, MAMS)

Why are alpha and delta faster than wild type?

How do virus variants arise and how do they spread? This is one of the key questions of a new research project initiated jointly by ...

Read more …
Fraunhofer ITMP uses high-tech methods for cell-based drug screening. (Picture: ©Fraunhofer ITMP)

Stem Cell-Based Translation

The North as a hub for global stem cell research: The 2021 Annual Meeting of the International Society for Stem Cell Research (ISSCR) was scheduled ...

Read more …
In addition to climate protection, funding schemes in Hamburg should also find their way into the fields of life science, infection and pandemic control, and digitalization. (Picture: ©Mediaserver Hamburg/Timo Sommer)

EUR 30 million in EU funds for projects in Hamburg

The European Commission has approved the use of EUR 30 million in funds for climate protection and innovation funds in Hamburg through 2023 as part ...

Read more …
Dr. Tanmay Bharat, Sir William Dunn School of Pathology, University of Oxford (Picture: ©Eppendorf AG)

Eppendorf Award for Young European Investigators 2021

In 2021, Eppendorf AG, the Hamburg life sciences company, is presenting its highly prestigious research prize for the 26th time. The independent ...

Read more …
May 26, 2021, is the effective date of the new EU regulation, which came into force four years ago. (Picture: ©Miriam Barton)

How to master the MDR challenge

How medical technology companies in the North succeed to deal with the new requirements of the Medical Device Regulation – even in uncertain times and ...

Read more …

Sysmex supports healthcare workers in fighting the pandemic

Sysmex Europe GmbH announces the launch of the HISCL™-5000 fully automated random-access immunochemistry analyser and the HISCL™ SARS-CoV-2 Ag Assay Kit ...

Read more …

Sysmex obtains the first IVDR certification

Sysmex Europe GmbH announced that LYNOAMP CK19 E [1], part of OSNATM [2] method using a molecular biological technique for cancer ...

Read more …